GENFIT Share Price Deutsche Boerse AG
Stocks
XUP
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.40 EUR | +27.62% |
|
+27.83% | +145.19% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 647M 739M 596M 553M 1.05B 70.5B 1.07B 7.14B 2.78B 34.61B 2.78B 2.71B 120B | P/E 2025 |
-3.06x | P/E 2026 * | 68.1x |
|---|---|---|---|---|---|
| Enterprise Value | 593M 677M 546M 507M 962M 64.54B 975M 6.53B 2.54B 31.68B 2.54B 2.49B 110B | EV / Sales 2025 |
2.34x | EV / Sales 2026 * | 6.31x |
| Free-Float |
86.88% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | +27.62% | ||
| 1 week | +27.83% | ||
| Current month | +22.48% | ||
| 1 month | +49.02% | ||
| 3 months | +71.93% | ||
| 6 months | +123.65% | ||
| Current year | +145.19% |
| 1 week | 10.18 |  | 12.86 |
| 1 month | 8.41 | | 12.86 |
| Current year | 5.08 | | 12.86 |
| 1 year | 3.01 | | 12.86 |
| 3 years | 2.8 | | 12.86 |
| 5 years | 2.74 | | 12.86 |
| 10 years | 2.74 | | 33.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 15/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 21/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 26/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 15/06/2017 | |
| Director/Board Member | 54 | 14/09/1999 | |
| Director/Board Member | 58 | 15/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +27.62% | +27.83% | - | - | 737M | |
| +1.08% | +7.56% | +4.01% | +9.84% | 49.92B | |
| +0.05% | -1.78% | +415.95% | +622.14% | 40.23B | |
| -0.22% | +6.91% | +27.20% | -5.06% | 34.55B | |
| +4.11% | +6.94% | +28.68% | +63.70% | 33.09B | |
| -4.19% | +6.03% | +3.76% | +32.17% | 27.51B | |
| -1.53% | +2.43% | - | - | 17.05B | |
| +0.27% | +4.60% | +75.40% | +139.05% | 15.92B | |
| -0.95% | +0.76% | +13.97% | +21.59% | 13.86B | |
| +2.20% | +3.73% | +100.34% | +100.43% | 13.52B | |
| Average | +2.79% | +5.72% | +83.66% | +122.98% | 27.3B | |
| Weighted average by Cap. | +0.21% | +6.43% | +94.82% | +140.89% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 66.82M 76.29M 61.54M 57.12M 108M 7.28B 110M 737M 287M 3.57B 287M 280M 12.39B | 95.2M 109M 87.68M 81.39M 155M 10.37B 157M 1.05B 408M 5.09B 408M 399M 17.65B |
| Net income | -8.3M -9.48M -7.65M -7.1M -13.48M -904M -13.66M -91.54M -35.62M -444M -35.6M -34.82M -1.54B | 18.63M 21.27M 17.16M 15.93M 30.24M 2.03B 30.65M 205M 79.93M 996M 79.88M 78.12M 3.45B |
| Net Debt | -54.72M -62.48M -50.4M -46.78M -88.84M -5.96B -90.04M -603M -235M -2.93B -235M -229M -10.14B | -46.87M -53.51M -43.17M -40.07M -76.09M -5.1B -77.12M -517M -201M -2.51B -201M -197M -8.69B |
| Date | Price | Change |
|---|---|---|
| 06/07/26 | €12.86 | +22.48% |
| 03/07/26 | €10.50 | -6.91% |
| 02/07/26 | €11.28 | +6.62% |
| 01/07/26 | €10.58 | +0.76% |
| 30/06/26 | €10.50 | +4.37% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
